Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
Corneal collagen crosslinking has been demonstrated as an effective method of reducing
progression of both keratoconus and post-refractive corneal ectasia, as well as decreasing
the steepness of the cornea in these pathologies.
Performing an accelerated CXL procedure with pulsed UVA light may increase the oxygenation of
the cornea, which may improve the crosslinking efficacy.